Skip to main content

Finance & Markets

Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript

CRO demand drove 11% revenue growth, though margin pressures from China sales tempered gains.

fool.com ·3h ago

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Read the original at fool.com →

More in Finance & Markets

Genasys stock rises on $1.4M LRAD orders from APAC, Europe

3h ago ·investing.com

Immunodiagnostics stock gains support from physician webinar feedback

3h ago ·investing.com

Crypto’s easy-money era is ending in a wave of failures

Inflated valuations and weak business models are driving crypto’s shakeout, Global Settlement Network CEO Ryan Kirkley says.

3h ago ·coindesk.com

Taylor Devices earnings missed by $0.31, revenue fell short of estimates

3h ago ·investing.com

Why is Prenetics stock rallying today?

3h ago ·investing.com

How Cellphones Solved A Problem The Power Grid Still Faces

The electricity grid is at a critical juncture, much like the telecom industry's past shift from landlines to wireless.

3h ago ·forbes.com

More from Tuesday 18 August →